Holleman, M. S., Al, M. J., Zaim, R., Groen, H. J. M., & Uyl-de Groot, C. A. (2019). Cost-effectiveness analysis of the first-line EGFR-TKIs in patients with non-small cell lung cancer harbouring EGFR mutations. Eur J Health Econ.
Chicago Style CitationHolleman, Marscha S., Maiwenn J. Al, Remziye Zaim, Harry J. M. Groen, i Carin A. Uyl-de Groot. "Cost-effectiveness Analysis of the First-line EGFR-TKIs in Patients With Non-small Cell Lung Cancer Harbouring EGFR Mutations." Eur J Health Econ 2019.
Cita MLAHolleman, Marscha S., et al. "Cost-effectiveness Analysis of the First-line EGFR-TKIs in Patients With Non-small Cell Lung Cancer Harbouring EGFR Mutations." Eur J Health Econ 2019.
Atenció: Aquestes cites poden no estar 100% correctes.